10-QPeriod: Q3 FY2013

TERADYNE, INC Quarterly Report for Q3 Ended Sep 29, 2013

Filed November 8, 2013For Securities:TER

Summary

Teradyne, Inc. (TER) reported its third quarter and nine-month results for the period ending September 29, 2013. For the nine months, net revenues decreased to $1.14 billion from $1.41 billion in the prior year, primarily driven by declines in Semiconductor Test and System Test segments, with lower demand in the hard disk drive market impacting System Test. Despite revenue challenges, gross profit as a percentage of revenue improved to 56.8% from 54.0% year-over-year, reflecting favorable product mix and lower inventory provisions. Cash and cash equivalents saw a significant increase, rising to $572.9 million from $338.9 million at the end of 2012, fueled by strong operating cash flow. The company ended the period with a healthy liquidity position. Teradyne completed the acquisition of ZTEC Instruments, Inc. and the sale of its equity interest in Empirix Inc. in October 2013, which are expected to impact future financial performance.

Financial Statements
Beta
Revenue$433.38M
Cost of Revenue$179.08M
Gross Profit$254.29M
SG&A Expenses$72.92M
Operating Expenses$160.79M
Operating Income$93.51M
Interest Expense$6.49M
Net Income$69.46M
EPS (Basic)$0.36
EPS (Diluted)$0.29
Shares Outstanding (Basic)191.31M
Shares Outstanding (Diluted)235.83M

Key Highlights

  • 1Total net revenues for the nine months ended September 29, 2013, decreased to $1.14 billion from $1.41 billion in the same period of 2012.
  • 2Gross profit margin improved to 56.8% for the nine months ended September 29, 2013, from 54.0% in the prior year's period.
  • 3Cash and cash equivalents increased significantly to $572.9 million as of September 29, 2013, from $338.9 million at December 31, 2012.
  • 4Net income for the nine months ended September 29, 2013, was $142.6 million, down from $233.6 million in the comparable period of 2012.
  • 5Operating expenses increased for the nine-month period, with Engineering & Development up to $199.4 million from $193.1 million, and Selling & Administrative expenses rising to $210.0 million from $207.7 million.
  • 6The company reported a book-to-bill ratio of 0.6 for the total company in Q3 2013, compared to 0.5 in Q3 2012, indicating a slight improvement in new orders relative to sales.
  • 7Teradyne completed the acquisition of ZTEC Instruments, Inc. and the divestiture of its equity interest in Empirix Inc. in October 2013.

Frequently Asked Questions